Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of ursodeoxycholic acid in prevention of cholestasis caused by total parenteral nutrition
IRCT20241123063815N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in neonatal cholestasis, sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
neonatal cholestasis
Beyond the preview
Go deeper on IRCT20241123063815N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241123063815N1.